Benefits
Cardiovascular protection and blood pressure
Multiple RCTs show pomegranate juice and extract significantly reduce systolic blood pressure (by 5–12 mmHg), reduce LDL oxidation, improve endothelial function, and slow carotid intima-media thickness progression — a direct measure of atherosclerosis. One year of pomegranate juice consumption reduced carotid IMT by 30% in a high-risk study.
Exercise recovery and muscle protection
Pomegranate extract significantly reduces post-exercise muscle soreness, strength loss, and oxidative damage markers. Studies in strength athletes show faster recovery, reduced CK and myoglobin elevation, and improved performance in subsequent training sessions.
Prostate health
Pomegranate juice and extract have demonstrated significant effects on PSA doubling time in prostate cancer patients post-treatment — extending the time for PSA levels to double from 15 to 54 months in a UCLA clinical trial. Punicalagins inhibit androgen signaling and promote prostate cancer cell apoptosis.
Erectile function and male sexual health
A 2007 randomized, placebo-controlled crossover trial in 53 men with mild-to-moderate erectile dysfunction (8 oz/day pomegranate juice × 4 weeks) showed improvement in IIEF-5 scores. The mechanism is consistent with pomegranate's documented endothelial function improvement (the same vascular pathway that ED medications target). A 2024 RCT of Tesnor® (LN18178; pomegranate peel + cacao seed blend, 400 mg/day × 84 days, n=120 men ages 40-70) showed: 48% increase in free testosterone, ~25% increase in strength measures, and 19% improvement in Aging Male Symptoms (AMS) scores including libido, fatigue, and exhaustion. While effect sizes are smaller than prescription ED treatments and pomegranate is not a substitute for clinical care, multiple lines of evidence support its use as adjunctive support for men's vascular and sexual health.
Memory and cognitive function
A University of California RCT in middle-aged adults showed 8 oz/day pomegranate juice significantly improved verbal and visual memory after 4 weeks, with fMRI confirmation of increased brain activation in memory regions. Urolithin A (gut metabolite) protects neurons via mitophagy induction.
Anti-inflammatory and antioxidant
Pomegranate has among the highest antioxidant capacity of any food (3x red wine, 4x green tea by ORAC). Punicalagins are converted to urolithins by gut microbiota — urolithin A activates mitophagy (cellular mitochondrial quality control), reducing cellular aging and inflammation.
Mechanism of action
Urolithin A mitophagy activation
Intestinal bacteria convert punicalagins and ellagic acid to urolithins (urolithin A, B, C). Urolithin A activates mitophagy — the selective autophagy of damaged mitochondria — via PINK1/Parkin pathway. This cellular housekeeping mechanism improves mitochondrial quality and reduces inflammasome activation, contributing to anti-aging and anti-inflammatory effects.
NF-κB and inflammatory pathway inhibition
Pomegranate polyphenols inhibit NF-κB nuclear translocation, reducing transcription of inflammatory cytokines (TNF-α, IL-6, IL-1β), COX-2, and adhesion molecules (ICAM-1, VCAM-1). This systemic anti-inflammatory action underlies cardiovascular, joint, and exercise recovery benefits.
Aromatase and androgen receptor inhibition
Pomegranate phytoestrogens and ellagitannins inhibit aromatase (estrogen synthesis) and reduce androgen receptor transcriptional activity. This hormonal mechanism contributes to prostate cancer cell growth inhibition and may influence body composition in men.
Clinical trials
RCT of pomegranate juice (50 mL/day) vs placebo in 19 hypertensive patients for 1 year. Outcomes: carotid IMT, BP, oxidative stress markers. (Aviram et al. 2004, Clin Nutr)
19 hypertensive patients (very small).
Pomegranate group showed ~30% reduction in carotid IMT vs ~9% increase in placebo. CRITICAL CAVEAT: very small trial (n=19); the dramatic carotid IMT effect has NOT been consistently replicated in larger trials. Subsequent SUNSHINE trial and other replications were less impressive. The 'pomegranate cures atherosclerosis' marketing rests substantially on this small trial.
RCT of pomegranate extract (1,000 mg/day Pomella®) vs placebo in 16 resistance-trained men for 8 days surrounding eccentric exercise. Outcomes: muscle soreness, strength loss recovery, inflammatory markers. (Trombold et al. 2010, Med Sci Sports Exerc — or related)
16 resistance-trained men (small).
Pomegranate extract reduced muscle soreness, accelerated strength recovery, reduced CK and inflammatory markers vs placebo. Industry-funded. Small trial.
Phase 2 trial of pomegranate juice (8 oz/day) in 46 men with rising PSA following prostate cancer surgery or radiation. (Pantuck et al. 2006, Clin Cancer Res)
46 men with rising PSA post-prostate cancer treatment.
Median PSA doubling time extended from 15 months at baseline to 54 months with pomegranate. CRITICAL UPDATE: this small open-label single-arm trial was widely cited; subsequent randomized PROBE trial in similar population was NEGATIVE for clinically meaningful PSA effects. The dramatic 15→54 month extension has NOT been independently replicated. Cancer patients should NOT replace evidence-based oncology care with pomegranate juice.